ID: ALA2070377

Max Phase: Preclinical

Molecular Formula: C22H30N2O18P2

Molecular Weight: 672.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-c2cn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H]3O)c(=O)[nH]c2=O)cc1

Standard InChI:  InChI=1S/C22H30N2O18P2/c1-37-10-4-2-9(3-5-10)11-6-24(22(32)23-19(11)31)20-17(29)15(27)13(39-20)8-38-43(33,34)42-44(35,36)41-21-18(30)16(28)14(26)12(7-25)40-21/h2-6,12-18,20-21,25-30H,7-8H2,1H3,(H,33,34)(H,35,36)(H,23,31,32)/t12-,13-,14+,15-,16+,17-,18-,20-,21-/m1/s1

Standard InChI Key:  PVCZKCNYRRPCHI-QQNRHZFDSA-N

Associated Targets(non-human)

N-acetyllactosaminide alpha-1,3-galactosyltransferase 17 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-1,4-galactosyltransferase 1 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 672.43Molecular Weight (Monoisotopic): 672.0969AlogP: -3.12#Rotatable Bonds: 11
Polar Surface Area: 306.22Molecular Species: ACIDHBA: 17HBD: 9
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.73CX Basic pKa: CX LogP: -3.49CX LogD: -8.24
Aromatic Rings: 2Heavy Atoms: 44QED Weighted: 0.11Np Likeness Score: 1.10

References

1. Descroix K, Pesnot T, Yoshimura Y, Gehrke SS, Wakarchuk W, Palcic MM, Wagner GK..  (2012)  Inhibition of galactosyltransferases by a novel class of donor analogues.,  55  (5): [PMID:22356319] [10.1021/jm201154p]

Source